Loading interface...

Betafree Eye Drops

Manufactured byMicro Labs Ltd.
ContainsBrinzolamide (10 mg/ml) + Brimonidine (2 mg/ml)
Description

Betafree Eye Drops is a combination medicine used for the treatment of increased eye pressure in patients suffering from open-angle glaucoma or ocular hypertension, conditions which may lead to eventual vision loss. This medicine is not recommended for use in patients less than 2 years of age.

Side effects

Major & minor side effects for Betafree Eye Drops

  • Blurred vision
  • Dry eyes
  • Redness, soreness, irritation or pain of the eye lid
  • Discharge from eyes
  • Double vision
  • Headache
  • Dizziness
  • Conjunctivitis

Uses of Betafree Eye Drops

What is it prescribed for?

  • Intraocular hypertension
  • Open angle Glaucoma
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 to 2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 12 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of adverse effects such as dizziness, drowsiness, difficulty concentrating, etc. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to brinzolamide, brimonidine, or any other inactive ingredients present along with these medicines.

Severe renal impairment

This medicine is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 ml/min) since the safety and efficacy of use are not clinically established for such patients.

Hyperchloremic Acidosis

This medicine is not recommended for use in patients with hyperchloremic acidosis since the safety and efficacy of use are not clinically established for such patients.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
General warnings

Liver impairment

This medicine should be used with caution in patients with a known history of liver diseases due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Corneal edema

This medicine should be used with caution since it increases the risk of corneal edema (swelling). This risk is especially higher in patients with a low number of endothelial cells. Report any eye swelling to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Driving or Operating machines

This medicine may cause blurred vision, dizziness, or drowsiness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Contact lens

This medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration of the eye drops and can be reinserted 15 minutes post administration.

Bacterial Keratitis

If this medicine is contaminated by bacteria, it can lead to an infection of the cornea (bacterial keratitis). Patients are advised to take all hygienic precautions to ensure that the medicine is not contaminated.

Cardiovascular diseases

This medicine should be used with caution in patients with cardiovascular diseases due to the increased risk of a very low blood pressure. Report any symptoms such as dizziness, fainting, changes in heart rate, etc. to the doctor immediately. Close monitoring of vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Use in pediatrics

This medicine is not recommended for use in patients less than 2 years of age. If the medicine is prescribed for patients less than 18 years of age, they should be monitored closely for any side effects and the side effects should be reported to the doctor immediately.

Missed Dose

Administer the missed dose as soon as you remember. It is advisable to skip the missed dose if it is almost time for your next scheduled dose. Do not instill a double dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of adverse effects such as dizziness, drowsiness, difficulty concentrating, etc. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Antihypertensives

Monoamine oxidase inhibitors

CNS depressants

Oral carbonic anhydrase inhibitors

Bismuth subsalicylate

Disease interactions

Hematologic toxicity

This medicine should be used with caution in patients with a previous history of blood cell disorders or bone marrow suppression due to the increased risk of worsening of the patient's condition. This risk is especially high if the medicine is used for a prolonged period of time. Close monitoring of complete blood counts is necessary for such patients. Report any symptoms such as a fever, sore throat, bleeding, pallor, or dizziness to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Renal Diseases

This medicine should be used with caution in patients with a history of renal diseases due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Depression

This medicine should be used with caution in patients suffering from depression due to the increased risk of worsening of the patient's condition. This risk is especially higher if the medicine is used for a prolonged period of time. Close monitoring of such patients for any change in mood or behavior is recommended. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Porphyria

This medicine should be used with extreme caution in patients suffering from porphyria due to the increased risk of an acute attack of porphyria. These patients should be monitored closely for any unusual symptoms. Emergency medical treatment may be needed if any symptoms such as severe abdominal pain, muscle pain, extreme weakness, anxiety, red or brown urine, etc. appear. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in such cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by reducing the fluid pressure inside the eyes.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Ophthalmic glaucoma agents

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 2 April 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204251s000lbl.pdf

[Internet]. Guildlink.com.au. 2018 [cited 2 April 2018]. Available from:

http://www.guildlink.com.au/gc/ws/nv/pi.cfm?product=nvpsibdr10717

[Internet]. Myglaucomasupport.com. 2018 [cited 2 April 2018]. Available from:

https://www.myglaucomasupport.com/simbrinza-suspension.shtml

DailyMed - Brinzolamide/brimonidine tartrate suspension/ drops [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 2 April 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a49c157e-6310-0011-7b7f-e26fc1820d59
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Jul 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.